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Our primary focus is enabling and accelerating biologi-
cal drug manufacture through the development of cost-
effective technologies that facilitate rapid bioprocess
development and improve manufacturing “bang-for-the-
buck”. Using data mining and cell-based screens we
have designed the Regocel™ small molecule yield
enhancers for a number of mammalian cell platforms
used in biomanufacturing such as CHO and NS0 cells.
Chemically defined molecules were screened against sev-
eral parameters: growth, viability and most importantly
protein production. Formulations were developed that
are defined, animal-free, non-nutritional and compatible
with different media, nutritional supplements, culture
formats and scales. Because they target ubiquitous cellu-
lar pathways such as apoptosis, cell cycle and protein
synthesis, these formulations provide consistent results
with a variety of clones and can shorten bioprocess
times and cost. Our results with Regocel™ supplements
demonstrated increased protein production in a variety
of commercial media (Figure 1), increased yields of dif-
ferent proteins such as antibodies and mammalian target
of rapamycin (mTOR), immediate yield enhancements
(from passage 1), and persistence of yield enhancements
over many passages with no permanent alterations to
cells, as determined by return of productivity to control
levels upon Regocel™ supplement removal from the
medium. These new small molecule formulations pro-
vide a new means of improving cell culture outcome
independently of mammalian cell clone, cell culture
medium and process.
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Figure 1 Antibody production by Chinese hamster ovary (CHO) cells increase with the Regocel™ small molecules (RS-CHO) in different
commercial media (M1-M6).
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